References
- Supreme Prosecution Service. White paper on drug-related crimes 2022. 1st ed. Seoul : Sungmin Enterprise. 2023 : 97-102.
- Doriety LJ, Farrington EA. Urine drug screening: what pediatric clinicians need to know to optimize patient care. J Pediatr Health Care. 2021 ; 35(4) : 449-55.
- Pope JD, Drummer OH, Schneider HG. False-positive amphetamines in urine drug screens: a 6-year review. J Anal Toxicol. 2023 ; 47(3) : 263-70.
- Lee SK, Choi S. Availability of urine toxicologic screening tests in the emergency department: focused on illegal drugs. J Korean Soc Clin Toxicol. 2021 ; 19(1) : 24-0.
- Han KH. 2020 Health technology reassessment report, tetrabromophenolphthalein ethylester. 1st ed. Seoul : National Evidence-based Healthcare Collaborating Agency. 2021 : 7-20.
- Ok YB, Kim JY, Lee KR, Hong DY, Baek KJ, Park SO, et al. A clinical review of patients who visited emergency medical center with positive methamphetamine tests: a single institute study. J Korean Soc Clin Toxicol. 2018 ; 16(1) : 25-32.
- Johnson-Davis KL, Sadler AJ, Genzen JR. A retrospective analysis of urine drugs of abuse immunoassay true positive rates at a national reference laboratory. J Anal Toxicol. 2016 ; 40(2) : 97-107.
- Tseng YL, Hsu HR, Kuo FH, Shieh MH, Chang CF. Ephedrines in over-the-counter cold medicines and urine specimens collected during sport competitions. J Anal Toxicol. 2003 ; 27(6) : 359-65.
- Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009 ; 104(7) : 1085-99.
- Nakae H, Hebiguchi M, Shirasaki S, Okuyama M, Masuda Y. Comparison of false-positive reactions for amphetamine analogs after maoto treatment using two urinary drug-screening kits. Tradit Kampo Med. 2014 ; 1(1) : 2-6.
- Kim JR, Yun SJ, Lee YK, Lee HJ, Kim JS. A review on safety of herbal medicines for doping. J Korean Med. 2019 ; 40(3) : 139-76.
- Strano-Rossi S, Leone D, de la Torre X, Botre F. The relevance of the urinary concentration of ephedrines in anti-doping analysis: determination of pseudoephedrine, cathine, and ephedrine after administration of over-thecounter medicaments. Ther Drug Monit. 2009 ; 31(4) : 520-6.
- Song M, Kim JO, Leem HH, Kim H. Stimultaneous determination of ephedrine alkaloids in Ephedra sinica and Wolbigachul-tang by high performance liquid chromatography. J Korean Med Obes Res. 2020 ; 20(2) : 97-108.
- Song MY, Kim HJ, Lee MJ. The safety guidelines for use of Ma-huang in obesity treatment. J Korean Med Obes Res. 2006 ; 6(2) : 17-27.
- Cho M, Kim S, Kim H, Song MY. Analysis of safety of Mahuang in studies for treatment of obesity. J Korean Med Obes Res. 2021 ; 21(2) : 95-104.
- White LM, Gardner SF, Gurley BJ, Marx MA, Wang PL, Estes M. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol. 1997 ; 37(2) : 116-22.
- Levisky JA, Karch SB, Bowerman DL, Jenkins WW, Johnson DG , Davies D. False-positive RIA for methamphetamine following ingestion of an ephedra-derived herbal product. J Anal Toxicol. 2003 ; 27(2) : 123-4.
- Nishiguchi M, Kinoshita H, Higasa K, Taniguchi T, Ouchi H, Minami T, et al. The false positive reaction of the triage panel drug-of-abuse by herbal drugs mahuang (Ephedra sinica (Ephedraceae)). Nihon Hoigaku Zasshi. 2001 ; 55(3) : 331-8.
- Park M, Choi H, Choi S, Son H, Lim M, Chung H. Cross-reactivity of amphetamine analogues in various immunoassays. Yakhak Hoeji. 2003 ; 47(5) : 266-70.